chr17-8096638-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_021628.3(ALOXE3):​c.2125G>A​(p.Val709Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000813 in 1,230,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000081 ( 0 hom. )

Consequence

ALOXE3
NM_021628.3 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.43
Variant links:
Genes affected
ALOXE3 (HGNC:13743): (arachidonate lipoxygenase 3) This gene is a member of the lipoxygenase family, which are catabolized by arachidonic acid-derived compounds. The encoded enzyme is a hydroperoxide isomerase that synthesizes a unique type of epoxy alcohol (8R-hydroxy-11R,12R-epoxyeicosa-5Z,9E,14Z-trienoic acid) from 12R-hydroperoxyeicosatetraenoic acid (12R-HPETE). This epoxy alcohol can activate the the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha), which is implicated in epidermal differentiation. Loss of function of the enzyme encoded by this gene results in ichthyosis, implicating the function of this gene in the differentiation of human skin. This gene is part of a cluster of lipoxygenase genes on 17p13.1. Mutations in this gene result in nonbullous congenital ichthyosiform erythroderma (NCIE). Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18668011).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ALOXE3NM_021628.3 linkuse as main transcriptc.2125G>A p.Val709Ile missense_variant 16/16 ENST00000448843.7 NP_067641.2
ALOXE3NM_001165960.1 linkuse as main transcriptc.2521G>A p.Val841Ile missense_variant 16/16 NP_001159432.1
ALOXE3NM_001369446.1 linkuse as main transcriptc.2122G>A p.Val708Ile missense_variant 15/15 NP_001356375.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ALOXE3ENST00000448843.7 linkuse as main transcriptc.2125G>A p.Val709Ile missense_variant 16/161 NM_021628.3 ENSP00000400581 P1Q9BYJ1-1
ALOXE3ENST00000380149.6 linkuse as main transcriptc.2125G>A p.Val709Ile missense_variant 15/151 ENSP00000369494 P1Q9BYJ1-1
ALOXE3ENST00000318227.4 linkuse as main transcriptc.2125G>A p.Val709Ile missense_variant 16/162 ENSP00000314879 P1Q9BYJ1-1
ALOXE3ENST00000583808.1 linkuse as main transcriptn.362G>A non_coding_transcript_exon_variant 2/24

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000813
AC:
10
AN:
1230608
Hom.:
0
Cov.:
19
AF XY:
0.0000112
AC XY:
7
AN XY:
623264
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000405
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000122
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000777
Gnomad4 OTH exome
AF:
0.0000190
GnomAD4 genome
Cov.:
32
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 16, 2024The c.2125G>A (p.V709I) alteration is located in exon 16 (coding exon 15) of the ALOXE3 gene. This alteration results from a G to A substitution at nucleotide position 2125, causing the valine (V) at amino acid position 709 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Uncertain
0.041
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.066
.;T;.
Eigen
Benign
0.0038
Eigen_PC
Benign
0.091
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.75
T;T;T
M_CAP
Benign
0.051
D
MetaRNN
Benign
0.19
T;T;T
MetaSVM
Benign
-0.35
T
MutationAssessor
Benign
0.72
.;N;.
MutationTaster
Benign
0.97
D;D;D
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.45
N;N;N
REVEL
Benign
0.27
Sift
Benign
0.23
T;T;T
Sift4G
Benign
0.41
T;T;T
Polyphen
0.93
.;P;.
Vest4
0.16
MutPred
0.48
.;Gain of glycosylation at S708 (P = 0.0929);.;
MVP
0.74
MPC
0.11
ClinPred
0.71
D
GERP RS
4.4
Varity_R
0.066
gMVP
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs967438626; hg19: chr17-7999956; API